The Oncosearch | Oncotarget

[¹⁸F]FDG and [¹⁸F]FES positron emission tomography for disease monitoring and assessment of anti-hormonal treatment eligibility in granulosa cell tumors of the ovary Research Paper

Joline F. Roze, Hannah S. van Meurs, Glen R. Monroe, Wouter B. Veldhuis, Luc R.C.W. van Lonkhuijzen, Roel J. Bennink, Jolijn W. Groeneweg, Petronella O. Witteveen, Geertruida N. Jonges, Ronald P. Zweemer, Arthur J.A.T. Braat

Published Mar 19, 2021 · Vol. 12, No. 7 · pp. 665-673

Keywords: positron emission tomography (PET), 18F-fluoroestradiol (¹⁸F-FES), 18F-fluoro-deoxyglucose (¹⁸F-FDG), granulosa cell tumors (GCTs), hormone receptors

The presence of polymorphisms in genes controlling neurotransmitter metabolism and disease prognosis in patients with prostate cancer: a possible link with schizophrenia Research Paper

Gennady M. Zharinov, Sergei E. Khalchitsky, Alexandre Loktionov, Marina V. Sogoyan, Yulia V. Khutoryanskaya, Natalia Yu. Neklasova, Oleg A. Bogomolov, Ilya V. Smirnov, Marina P. Samoilovich, Vladimir N. Skakun, Sergei V. Vissarionov, Vladimir N. Anisimov

Published Mar 12, 2021 · Vol. 12, No. 7 · pp. 698-707

Keywords: prostate cancer, prostate-specific antigen, disease prognosis, neurotransmitters metabolism genes, psychiatric disorders

Development of a ghrelin receptor inverse agonist for positron emission tomography Research Paper

Ralf Bergmann, Constance Chollet, Sylvia Els-Heindl, Martin Ullrich, Nicole Berndt, Jens Pietzsch, Domokos Máthé, Michael Bachmann, Annette G. Beck-Sickinger

Published Feb 7, 2021 · Vol. 12, No. 5 · pp. 450-474

Keywords: cancer, prostate cancer, growth hormone secretagogue receptor (GHS-R), small animal imaging, copper-64

Phase 1 study of Z-endoxifen in patients with advanced gynecologic, desmoid, and hormone receptor-positive solid tumors Research Paper

Naoko Takebe, Geraldine O'Sullivan Coyne, Shivaani Kummar, Jerry Collins, Joel M. Reid, Richard Piekarz, Nancy Moore, Lamin Juwara, Barry C. Johnson, Rachel Bishop, Frank I. Lin, Esther Mena, Peter L. Choyke, M. Liza Lindenberg, Larry V. Rubinstein, Cecilia Monge Bonilla, Matthew P. Goetz, Matthew M. Ames, Renee M. McGovern, Howard Streicher, Joseph M. Covey, James H. Doroshow, Alice P. Chen

Published Feb 1, 2021 · Vol. 12, No. 4 · pp. 268-277

Keywords: Z-endoxifen, phase 1, tamoxifen, pharmacokinetics

STAT3 induces the expression of GLI1 in chronic lymphocytic leukemia cells Research Paper

Uri Rozovski, David M. Harris, Ping Li, Zhiming Liu, Preetesh Jain, Taghi Manshouri, Ivo Veletic, Alessandra Ferrajoli, Prithviraj Bose, Phillip Thompson, Nitin Jain, Srdan Verstovsek, William Wierda, Michael J. Keating, Zeev Estrov

Published Jan 30, 2021 · Vol. 12, No. 5 · pp. 401-411

Keywords: CLL, STAT3, GLI1, apoptosis, transcription

Head to head evaluation of second generation ALK inhibitors brigatinib and alectinib as first-line treatment for ALK+ NSCLC using an in silico systems biology-based approach Research Paper

Enric Carcereny, Alonso Fernández-Nistal, Araceli López, Carmen Montoto, Andrea Naves, Cristina Segú-Vergés, Mireia Coma, Guillem Jorba, Baldomero Oliva, Jose Manuel Mas

Published Jan 22, 2021 · Vol. 12, No. 4 · pp. 316-332

Keywords: ALK inhibitor, brigatinib, alectinib, mathematical model, systems biology

Characterization of FGFR signaling in prostate cancer stem cells and inhibition via TKI treatment Research Paper

Juyeon Ko, April N. Meyer, Martin Haas, Daniel J. Donoghue

Published Dec 23, 2020 · Vol. 12, No. 1 · pp. 22-36

Keywords: metastatic castrate-resistant prostate cancer, spheroid culture, tyrosine kinase inhibitor

Harmonized pretreatment quantitative volume-based FDG-PET/CT parameters for prognosis of stage I–III breast cancer: Multicenter study Research Paper

Kazuhiro Kitajima, Yasuo Miyoshi, Tetsuro Sekine, Hiroyuki Takei, Kimiteru Ito, Akihiko Suto, Hayato Kaida, Kazunari Ishii, Hiromitsu Daisaki, Koichiro Yamakado

Published Dec 16, 2020 · Vol. 12, No. 2 · pp. 95-105

Keywords: breast cancer, survival, fluorodeoxyglucose (FDG), positron emission tomography-computed tomography (PET-CT), harmonization

PELP-1 regulates adverse responses to endocrine therapy in Estrogen Receptor (ER) positive breast cancer Research Paper

Michael Rees, Chris Smith, Peter Barrett-Lee, Steve Hiscox

Published Dec 11, 2020 · Vol. 11, No. 51 · pp. 4722-4734

Keywords: breast cancer, PELP-1, ER+, invasion

Novel 3-(3, 5-difluoro-4-hydroxyphenyl)-1-(naphthalen-2-yl) prop-2-en-1-one as a potent inhibitor of MAP-kinase in HeLa cell lines and anti-angiogenic activity is mediated by HIF-1α in EAC animal model Research Paper

Dileep Kumar M. Guruswamy, Kyathegowdana Doddi Srivinavasa Balaji, Kattepura Krishnappa Dharmappa, Shankar Jayarama

Published Nov 27, 2020 · Vol. 11, No. 50 · pp. 4661-4676

Keywords: novel chalcone, Bcl2, caspase 3, BAX, receptor tyrosine kinase inhibitor

Immune-stimulatory (TK/Flt3L) gene therapy opens the door to a promising new treatment strategy against brainstem gliomas Research Perspective

Syed M. Faisal, Flor M. Mendez, Fernando Nunez, Maria G. Castro, Pedro R. Lowenstein

Published Nov 27, 2020 · Vol. 11, No. 50 · pp. 4607-4612

Keywords: immunotherapy, gene therapy, thymidine kinase, Flt3L, DIPG

Immune profiling of the bone marrow microenvironment in patients with high-risk localized prostate cancer Research Paper

Erika Heninger, Nan Sethakorn, David Kosoff, Peiman Hematti, Morgan D. Kuczler, Kenneth J. Pienta, Joshua M. Lang

Published Nov 10, 2020 · Vol. 11, No. 46 · pp. 4253-4265

Keywords: prostate cancer, bone marrow, tumor microenvironment, immune profiling, immune landscape

Identification of Mubritinib (TAK 165) as an inhibitor of KSHV driven primary effusion lymphoma via disruption of mitochondrial OXPHOS metabolism Research Paper

Abram Calderon, Samantha S. Soldan, Alessandra De Leo, Zhong Deng, Drew M. Frase, Emma M. Anderson, Yue Zhang, Olga Vladimirova, Fang Lu, Jessica C. Leung, Maureen E. Murphy, Paul M. Lieberman

Published Nov 7, 2020 · Vol. 11, No. 46 · pp. 4224-4242

Keywords: KSHV, LANA, high-throughput screen (HTS), primary effusion lymphoma, Mubritinib

MicroRNA-based regulation of Aurora A kinase in breast cancer Research Paper

Adewale Oluwaseun Fadaka, Nicole Remaliah Samantha Sibuyi, Abram Madimabe Madiehe, Mervin Meyer

Published Nov 6, 2020 · Vol. 11, No. 46 · pp. 4306-4324

Keywords: AURKA, breast cancer therapy, regulatory microRNA, human argonaute, gene expression

A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancer Case Report

Sewanti Limaye, Prashant Kumar, Ramya Pragya, Janani Sambath, Darshana Patil, Ajay Srinivasan, Sachin Apurva, Navin Srivastava, Sanket Patil, Revati Patil, Vineet Datta, Dadasaheb Akolkar, Rajan Datar

Published Nov 5, 2020 · Vol. 11, No. 46 · pp. 4358-4363

Keywords: high grade serous ovarian cancer, androgen receptors, bicalutamide

Association between vitamin D and ovarian cancer development in BRCA1 mutation carriers Research Paper

Tanja Pejovic, Sonali Joshi, Shawn Campbell, Sarah Thisted, Fuhua Xu, Jing Xu

Published Nov 4, 2020 · Vol. 11, No. 45 · pp. 4104-4114

Keywords: epithelial ovarian cancer, BRCA1 mutation carriers, vitamin D, cancer prevention

T-cell redirecting bispecific antibodies targeting BCMA for the treatment of multiple myeloma Research Perspective

Christie P.M. Verkleij, Kristine A. Frerichs, Marloes Broekmans, Saida Absalah, Patricia W.C. Maas-Bosman, Sandy Kruyswijk, Inger S. Nijhof, Tuna Mutis, Sonja Zweegman, Niels W.C.J. van de Donk

Published Oct 24, 2020 · Vol. 11, No. 45 · pp. 4076-4081

Keywords: multiple myeloma, bispecific antibody, immunotherapy, BCMA, CD38

HER2 splice variants in breast cancer: investigating their impact on diagnosis and treatment outcomes Review

Vic Hart, Hannah Gautrey, John Kirby, Alison Tyson-Capper

Published Oct 22, 2020 · Vol. 11, No. 46 · pp. 4338-4357

Keywords: HER2, Δ16-HER2, splice variant, breast cancer, trastuzumab

Biomarkers and novel therapeutic approaches for diffuse large B-cell lymphoma in the era of precision medicine Review

Niraj Lodhi, Moe Tun, Poonam Nagpal, Arati A. Inamdar, Nehad M. Ayoub, Noor Siyam, Lucia Oton-Gonzalez, Angela Gerona, Dainelle Morris, Rana Sandhu, Kwangsun Stephen Suh

Published Oct 20, 2020 · Vol. 11, No. 44 · pp. 4045-4073

Keywords: DLBCL, diagnosis, R-CHOP, precision medicine, prognosis

Heterogeneity of CEACAM5 in breast cancer Research Paper

Marc B. Bechmann, Andreas V. Brydholm, Victoria L. Codony, Jiyoung Kim, René Villadsen

Published Oct 7, 2020 · Vol. 11, No. 43 · pp. 3886-3899

Keywords: CEACAM5, CEA, immunohistochemistry, breast cancer, invasion

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

[¹⁸F]FDG and [¹⁸F]FES positron emission tomography for disease monitoring and assessment of anti-hormonal treatment eligibility in granulosa cell tumors of the ovary Research Paper

The presence of polymorphisms in genes controlling neurotransmitter metabolism and disease prognosis in patients with prostate cancer: a possible link with schizophrenia Research Paper

Development of a ghrelin receptor inverse agonist for positron emission tomography Research Paper

Phase 1 study of Z-endoxifen in patients with advanced gynecologic, desmoid, and hormone receptor-positive solid tumors Research Paper

STAT3 induces the expression of GLI1 in chronic lymphocytic leukemia cells Research Paper

Head to head evaluation of second generation ALK inhibitors brigatinib and alectinib as first-line treatment for ALK+ NSCLC using an in silico systems biology-based approach Research Paper

Characterization of FGFR signaling in prostate cancer stem cells and inhibition via TKI treatment Research Paper

Harmonized pretreatment quantitative volume-based FDG-PET/CT parameters for prognosis of stage I–III breast cancer: Multicenter study Research Paper

PELP-1 regulates adverse responses to endocrine therapy in Estrogen Receptor (ER) positive breast cancer Research Paper

Novel 3-(3, 5-difluoro-4-hydroxyphenyl)-1-(naphthalen-2-yl) prop-2-en-1-one as a potent inhibitor of MAP-kinase in HeLa cell lines and anti-angiogenic activity is mediated by HIF-1α in EAC animal model Research Paper

Immune-stimulatory (TK/Flt3L) gene therapy opens the door to a promising new treatment strategy against brainstem gliomas Research Perspective

Immune profiling of the bone marrow microenvironment in patients with high-risk localized prostate cancer Research Paper

Identification of Mubritinib (TAK 165) as an inhibitor of KSHV driven primary effusion lymphoma via disruption of mitochondrial OXPHOS metabolism Research Paper

MicroRNA-based regulation of Aurora A kinase in breast cancer Research Paper

A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancer Case Report

Association between vitamin D and ovarian cancer development in BRCA1 mutation carriers Research Paper

T-cell redirecting bispecific antibodies targeting BCMA for the treatment of multiple myeloma Research Perspective

HER2 splice variants in breast cancer: investigating their impact on diagnosis and treatment outcomes Review

Biomarkers and novel therapeutic approaches for diffuse large B-cell lymphoma in the era of precision medicine Review

Heterogeneity of CEACAM5 in breast cancer Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

[18F]FDG and [18F]FES positron emission tomography for disease monitoring and assessment of anti-hormonal treatment eligibility in granulosa cell tumors of the ovary Research Paper

The presence of polymorphisms in genes controlling neurotransmitter metabolism and disease prognosis in patients with prostate cancer: a possible link with schizophrenia Research Paper

Development of a ghrelin receptor inverse agonist for positron emission tomography Research Paper

Phase 1 study of Z-endoxifen in patients with advanced gynecologic, desmoid, and hormone receptor-positive solid tumors Research Paper

STAT3 induces the expression of GLI1 in chronic lymphocytic leukemia cells Research Paper

Head to head evaluation of second generation ALK inhibitors brigatinib and alectinib as first-line treatment for ALK+ NSCLC using an in silico systems biology-based approach Research Paper

Characterization of FGFR signaling in prostate cancer stem cells and inhibition via TKI treatment Research Paper

Harmonized pretreatment quantitative volume-based FDG-PET/CT parameters for prognosis of stage I–III breast cancer: Multicenter study Research Paper

PELP-1 regulates adverse responses to endocrine therapy in Estrogen Receptor (ER) positive breast cancer Research Paper

Novel 3-(3, 5-difluoro-4-hydroxyphenyl)-1-(naphthalen-2-yl) prop-2-en-1-one as a potent inhibitor of MAP-kinase in HeLa cell lines and anti-angiogenic activity is mediated by HIF-1α in EAC animal model Research Paper

Immune-stimulatory (TK/Flt3L) gene therapy opens the door to a promising new treatment strategy against brainstem gliomas Research Perspective

Immune profiling of the bone marrow microenvironment in patients with high-risk localized prostate cancer Research Paper

Identification of Mubritinib (TAK 165) as an inhibitor of KSHV driven primary effusion lymphoma via disruption of mitochondrial OXPHOS metabolism Research Paper

MicroRNA-based regulation of Aurora A kinase in breast cancer Research Paper

A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancer Case Report

Association between vitamin D and ovarian cancer development in BRCA1 mutation carriers Research Paper

T-cell redirecting bispecific antibodies targeting BCMA for the treatment of multiple myeloma Research Perspective

HER2 splice variants in breast cancer: investigating their impact on diagnosis and treatment outcomes Review

Biomarkers and novel therapeutic approaches for diffuse large B-cell lymphoma in the era of precision medicine Review

Heterogeneity of CEACAM5 in breast cancer Research Paper

[¹⁸F]FDG and [¹⁸F]FES positron emission tomography for disease monitoring and assessment of anti-hormonal treatment eligibility in granulosa cell tumors of the ovary Research Paper